1[1]Soloway M S,Briggman J V,Carpinito G A,et al. Use of a new tumor maker,urinary NMP22 in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment. J Urol,1996,156:363-367. 被引量：1
2[2]Gutierrez B J L,Rebollo R M H,Antolin J F M,et al. NMP 22,BTA stat test and cytology in the diagnosis of bladder cancer: a comparative study. Urol Int ,2001,66:185-190. 被引量：1
3[3]Miyanaga N ,Akaza H,Ishikawa S,et al. Clinical evaluation of nuclear matrix protein 22(NMP22) in urine as a novel marker for urothelial cancer. Eur Urol,1997,31:163-168. 被引量：1
4[4]Fukui Y,Samma S,Fujimoto K,et al. Screening methods in the detection of bladder cancer: comparison of nuclear matrix protein-22,bladder tumor antigen and cytological examinations. Hinyokika Kiyo,2001,47:311-314. 被引量：1
5[5]Atsu N,Ekici S,Oge O O,et al. False-positive results of the NMP22 test due to hematuria. .J Urol,2002 ,167(2 Pt 1):555-558. 被引量：1
6[6]Ponsky L E,Sharma S,Pandrangi L,et al. Screening and monitoring for bladder cancer: refining the use of NMP22. J Urol,2001,166:75-78. 被引量：1
7[7]Lahme S,Bichler K H,Feil G.Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer. Urol Int,2001,66:72-77. 被引量：1
8[8]Saad A,Hanbury D C,McNicholas T A.A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int ,2002 ,89:369-373. 被引量：1
9[9]Nero D A,Esposito N,Currro A,et al. Evaluation of urinary level of NMP22 as a diagnostic marker for stage pTa-pT1 bladder cancer :comparison with urinary cytology and BTA test. Eur Urol,1999,35:93-97. 被引量：1
10[10]Akaza H,Miyanaga N ,Tsukamato T,et al. Evaluation of urinary NMP22 (nuclear matrix protein 22) as a diagnostic marker for urothelial cancer-NMP22 as a urinary marker for surveillance of bladder cancer. NMP22 Study Group. Gan To Kagaku Ryoho,1997,24:829-836. 被引量：1
同被引文献11
1BHUIYAN J, AKHTER J, O'KANE D J. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder [ J ] .Clin Chim Acta, 2003, 33( 2 ): 69-77. 被引量：1
2EISSA S, SWELLAM M, SADEK M, et al. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors [ J ]. J Urol, 2002, 168( 2 ): 465-469. 被引量：1
3POULAKIS V, WITZSCH U, DE VRIES R, et al. A comparison of urinary nuclear matrix protein-22 and bladder tumor antigen tests with voided urinary cytology in detecting and following bladder cancer; the prognostic value of false-positive results [ J ]. BJU Int, 2001, 88( 7 ): 692-701. 被引量：1
5LEE K H. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer [ J ] .Yonsei Med J, 2001,42( 1 ): 14-18. 被引量：1
6ZIPPE C, PANDRANGI L, AHARWAL A. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer [ J ]. J Urol, 1999, 161( 1 ): 62-65. 被引量：1
7PAPANICOLAOU G N, MARSHAL V F. Urine sediment smears : a diagnostic procedure in cancer of the urinary tract. [ J ]. Science,1945, 101: 519-520. 被引量：1
